GB Patent

GB201319791D0 — Formulations

Assigned to Sigmoid Pharma Ltd · Expires 2013-12-25 · 12y expired

What this patent protects

Patent listed against Solosec.

Drugs covered by this patent

Solosec (SECNIDAZOLE) · Evofem Inc

Patent Metadata

Patent number: GB201319791D0
Jurisdiction: GB
Classification: —
Expires: 2013-12-25
Drug substance claim: No
Drug product claim: No
Assignee: Sigmoid Pharma Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.